世界の高眼圧症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Ocular Hypertension Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4224
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、高眼圧症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（高眼圧症、緑内障）、用途別市場規模（病院、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・高眼圧症治療の市場動向
・企業の競争状況、市場シェア
・高眼圧症治療の種類別市場規模（高眼圧症、緑内障）
・高眼圧症治療の用途別市場規模（病院、専門クリニック、その他）
・高眼圧症治療の北米市場規模2016-2027（アメリカ、カナダ）
・高眼圧症治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・高眼圧症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・高眼圧症治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・高眼圧症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Aerie Pharmaceuticals, Inc.、Allergan plc、Angelini Group、Chong Kun Dang Pharmaceutical Corp.、SALVAT SA、Sophia SA de CV、Lee's Pharmaceutical Holdings Ltd.、Neurim Pharmaceuticals Ltd.、NicOx SA、Novartis AG）
・結論

Ocular hypertension is caused by poor drainage of the fluid inside the eye. Essentially, this means that too much fluid enters the eye without being drained, causing high amount of pressure to build up.

Market Analysis and Insights: Global Ocular Hypertension Treatment Market
The global Ocular Hypertension Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Ocular Hypertension Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Ocular Hypertension Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Ocular Hypertension Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Ocular Hypertension Treatment market.

Global Ocular Hypertension Treatment Scope and Market Size
Ocular Hypertension Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Ocular Hypertension Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Intraocular Hypertension
Glaucoma

Segment by Application
Hospitals
Specialty Clinics
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Aerie Pharmaceuticals, Inc.
Allergan plc
Angelini Group
Chong Kun Dang Pharmaceutical Corp.
SALVAT SA
Sophia SA de CV
Lee’s Pharmaceutical Holdings Ltd.
Neurim Pharmaceuticals Ltd.

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ocular Hypertension Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Intraocular Hypertension
1.2.3 Glaucoma
1.3 Market by Application
1.3.1 Global Ocular Hypertension Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Ocular Hypertension Treatment Market Perspective (2016-2027)
2.2 Ocular Hypertension Treatment Growth Trends by Regions
2.2.1 Ocular Hypertension Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Ocular Hypertension Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Ocular Hypertension Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Ocular Hypertension Treatment Industry Dynamic
2.3.1 Ocular Hypertension Treatment Market Trends
2.3.2 Ocular Hypertension Treatment Market Drivers
2.3.3 Ocular Hypertension Treatment Market Challenges
2.3.4 Ocular Hypertension Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Ocular Hypertension Treatment Players by Revenue
3.1.1 Global Top Ocular Hypertension Treatment Players by Revenue (2016-2021)
3.1.2 Global Ocular Hypertension Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Ocular Hypertension Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Ocular Hypertension Treatment Revenue
3.4 Global Ocular Hypertension Treatment Market Concentration Ratio
3.4.1 Global Ocular Hypertension Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ocular Hypertension Treatment Revenue in 2020
3.5 Ocular Hypertension Treatment Key Players Head office and Area Served
3.6 Key Players Ocular Hypertension Treatment Product Solution and Service
3.7 Date of Enter into Ocular Hypertension Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Ocular Hypertension Treatment Breakdown Data by Type
4.1 Global Ocular Hypertension Treatment Historic Market Size by Type (2016-2021)
4.2 Global Ocular Hypertension Treatment Forecasted Market Size by Type (2022-2027)

5 Ocular Hypertension Treatment Breakdown Data by Application
5.1 Global Ocular Hypertension Treatment Historic Market Size by Application (2016-2021)
5.2 Global Ocular Hypertension Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Ocular Hypertension Treatment Market Size (2016-2027)
6.2 North America Ocular Hypertension Treatment Market Size by Type
6.2.1 North America Ocular Hypertension Treatment Market Size by Type (2016-2021)
6.2.2 North America Ocular Hypertension Treatment Market Size by Type (2022-2027)
6.2.3 North America Ocular Hypertension Treatment Market Size by Type (2016-2027)
6.3 North America Ocular Hypertension Treatment Market Size by Application
6.3.1 North America Ocular Hypertension Treatment Market Size by Application (2016-2021)
6.3.2 North America Ocular Hypertension Treatment Market Size by Application (2022-2027)
6.3.3 North America Ocular Hypertension Treatment Market Size by Application (2016-2027)
6.4 North America Ocular Hypertension Treatment Market Size by Country
6.4.1 North America Ocular Hypertension Treatment Market Size by Country (2016-2021)
6.4.2 North America Ocular Hypertension Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Ocular Hypertension Treatment Market Size (2016-2027)
7.2 Europe Ocular Hypertension Treatment Market Size by Type
7.2.1 Europe Ocular Hypertension Treatment Market Size by Type (2016-2021)
7.2.2 Europe Ocular Hypertension Treatment Market Size by Type (2022-2027)
7.2.3 Europe Ocular Hypertension Treatment Market Size by Type (2016-2027)
7.3 Europe Ocular Hypertension Treatment Market Size by Application
7.3.1 Europe Ocular Hypertension Treatment Market Size by Application (2016-2021)
7.3.2 Europe Ocular Hypertension Treatment Market Size by Application (2022-2027)
7.3.3 Europe Ocular Hypertension Treatment Market Size by Application (2016-2027)
7.4 Europe Ocular Hypertension Treatment Market Size by Country
7.4.1 Europe Ocular Hypertension Treatment Market Size by Country (2016-2021)
7.4.2 Europe Ocular Hypertension Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Ocular Hypertension Treatment Market Size (2016-2027)
8.2 Asia-Pacific Ocular Hypertension Treatment Market Size by Type
8.2.1 Asia-Pacific Ocular Hypertension Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Ocular Hypertension Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Ocular Hypertension Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Ocular Hypertension Treatment Market Size by Application
8.3.1 Asia-Pacific Ocular Hypertension Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Ocular Hypertension Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Ocular Hypertension Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Ocular Hypertension Treatment Market Size by Region
8.4.1 Asia-Pacific Ocular Hypertension Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Ocular Hypertension Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Ocular Hypertension Treatment Market Size (2016-2027)
9.2 Latin America Ocular Hypertension Treatment Market Size by Type
9.2.1 Latin America Ocular Hypertension Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Ocular Hypertension Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Ocular Hypertension Treatment Market Size by Type (2016-2027)
9.3 Latin America Ocular Hypertension Treatment Market Size by Application
9.3.1 Latin America Ocular Hypertension Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Ocular Hypertension Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Ocular Hypertension Treatment Market Size by Application (2016-2027)
9.4 Latin America Ocular Hypertension Treatment Market Size by Country
9.4.1 Latin America Ocular Hypertension Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Ocular Hypertension Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Ocular Hypertension Treatment Market Size (2016-2027)
10.2 Middle East & Africa Ocular Hypertension Treatment Market Size by Type
10.2.1 Middle East & Africa Ocular Hypertension Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Ocular Hypertension Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Ocular Hypertension Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Ocular Hypertension Treatment Market Size by Application
10.3.1 Middle East & Africa Ocular Hypertension Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Ocular Hypertension Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Ocular Hypertension Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Ocular Hypertension Treatment Market Size by Country
10.4.1 Middle East & Africa Ocular Hypertension Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Ocular Hypertension Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Aerie Pharmaceuticals, Inc.
11.1.1 Aerie Pharmaceuticals, Inc. Company Details
11.1.2 Aerie Pharmaceuticals, Inc. Business Overview
11.1.3 Aerie Pharmaceuticals, Inc. Ocular Hypertension Treatment Introduction
11.1.4 Aerie Pharmaceuticals, Inc. Revenue in Ocular Hypertension Treatment Business (2016-2021)
11.1.5 Aerie Pharmaceuticals, Inc. Recent Development
11.2 Allergan plc
11.2.1 Allergan plc Company Details
11.2.2 Allergan plc Business Overview
11.2.3 Allergan plc Ocular Hypertension Treatment Introduction
11.2.4 Allergan plc Revenue in Ocular Hypertension Treatment Business (2016-2021)
11.2.5 Allergan plc Recent Development
11.3 Angelini Group
11.3.1 Angelini Group Company Details
11.3.2 Angelini Group Business Overview
11.3.3 Angelini Group Ocular Hypertension Treatment Introduction
11.3.4 Angelini Group Revenue in Ocular Hypertension Treatment Business (2016-2021)
11.3.5 Angelini Group Recent Development
11.4 Chong Kun Dang Pharmaceutical Corp.
11.4.1 Chong Kun Dang Pharmaceutical Corp. Company Details
11.4.2 Chong Kun Dang Pharmaceutical Corp. Business Overview
11.4.3 Chong Kun Dang Pharmaceutical Corp. Ocular Hypertension Treatment Introduction
11.4.4 Chong Kun Dang Pharmaceutical Corp. Revenue in Ocular Hypertension Treatment Business (2016-2021)
11.4.5 Chong Kun Dang Pharmaceutical Corp. Recent Development
11.5 SALVAT SA
11.5.1 SALVAT SA Company Details
11.5.2 SALVAT SA Business Overview
11.5.3 SALVAT SA Ocular Hypertension Treatment Introduction
11.5.4 SALVAT SA Revenue in Ocular Hypertension Treatment Business (2016-2021)
11.5.5 SALVAT SA Recent Development
11.6 Sophia SA de CV
11.6.1 Sophia SA de CV Company Details
11.6.2 Sophia SA de CV Business Overview
11.6.3 Sophia SA de CV Ocular Hypertension Treatment Introduction
11.6.4 Sophia SA de CV Revenue in Ocular Hypertension Treatment Business (2016-2021)
11.6.5 Sophia SA de CV Recent Development
11.7 Lee’s Pharmaceutical Holdings Ltd.
11.7.1 Lee’s Pharmaceutical Holdings Ltd. Company Details
11.7.2 Lee’s Pharmaceutical Holdings Ltd. Business Overview
11.7.3 Lee’s Pharmaceutical Holdings Ltd. Ocular Hypertension Treatment Introduction
11.7.4 Lee’s Pharmaceutical Holdings Ltd. Revenue in Ocular Hypertension Treatment Business (2016-2021)
11.7.5 Lee’s Pharmaceutical Holdings Ltd. Recent Development
11.8 Neurim Pharmaceuticals Ltd.
11.8.1 Neurim Pharmaceuticals Ltd. Company Details
11.8.2 Neurim Pharmaceuticals Ltd. Business Overview
11.8.3 Neurim Pharmaceuticals Ltd. Ocular Hypertension Treatment Introduction
11.8.4 Neurim Pharmaceuticals Ltd. Revenue in Ocular Hypertension Treatment Business (2016-2021)
11.8.5 Neurim Pharmaceuticals Ltd. Recent Development
11.9 NicOx SA
11.9.1 NicOx SA Company Details
11.9.2 NicOx SA Business Overview
11.9.3 NicOx SA Ocular Hypertension Treatment Introduction
11.9.4 NicOx SA Revenue in Ocular Hypertension Treatment Business (2016-2021)
11.9.5 NicOx SA Recent Development
11.10 Novartis AG
11.10.1 Novartis AG Company Details
11.10.2 Novartis AG Business Overview
11.10.3 Novartis AG Ocular Hypertension Treatment Introduction
11.10.4 Novartis AG Revenue in Ocular Hypertension Treatment Business (2016-2021)
11.10.5 Novartis AG Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Ocular Hypertension Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Intraocular Hypertension
Table 3. Key Players of Glaucoma
Table 4. Global Ocular Hypertension Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Ocular Hypertension Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Ocular Hypertension Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Ocular Hypertension Treatment Market Share by Regions (2016-2021)
Table 8. Global Ocular Hypertension Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Ocular Hypertension Treatment Market Share by Regions (2022-2027)
Table 10. Ocular Hypertension Treatment Market Trends
Table 11. Ocular Hypertension Treatment Market Drivers
Table 12. Ocular Hypertension Treatment Market Challenges
Table 13. Ocular Hypertension Treatment Market Restraints
Table 14. Global Ocular Hypertension Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Ocular Hypertension Treatment Market Share by Players (2016-2021)
Table 16. Global Top Ocular Hypertension Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ocular Hypertension Treatment as of 2020)
Table 17. Ranking of Global Top Ocular Hypertension Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Ocular Hypertension Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Ocular Hypertension Treatment Product Solution and Service
Table 21. Date of Enter into Ocular Hypertension Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Ocular Hypertension Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Ocular Hypertension Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Ocular Hypertension Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Ocular Hypertension Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Ocular Hypertension Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Ocular Hypertension Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Ocular Hypertension Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Ocular Hypertension Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Ocular Hypertension Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Ocular Hypertension Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Ocular Hypertension Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Ocular Hypertension Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Ocular Hypertension Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Ocular Hypertension Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Ocular Hypertension Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Ocular Hypertension Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Ocular Hypertension Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Ocular Hypertension Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Ocular Hypertension Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Ocular Hypertension Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Ocular Hypertension Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Ocular Hypertension Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Ocular Hypertension Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Ocular Hypertension Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Ocular Hypertension Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Ocular Hypertension Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Ocular Hypertension Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Ocular Hypertension Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Ocular Hypertension Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Ocular Hypertension Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Ocular Hypertension Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Ocular Hypertension Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Ocular Hypertension Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Ocular Hypertension Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Ocular Hypertension Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Ocular Hypertension Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Ocular Hypertension Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Ocular Hypertension Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Aerie Pharmaceuticals, Inc. Company Details
Table 62. Aerie Pharmaceuticals, Inc. Business Overview
Table 63. Aerie Pharmaceuticals, Inc. Ocular Hypertension Treatment Product
Table 64. Aerie Pharmaceuticals, Inc. Revenue in Ocular Hypertension Treatment Business (2016-2021) & (US$ Million)
Table 65. Aerie Pharmaceuticals, Inc. Recent Development
Table 66. Allergan plc Company Details
Table 67. Allergan plc Business Overview
Table 68. Allergan plc Ocular Hypertension Treatment Product
Table 69. Allergan plc Revenue in Ocular Hypertension Treatment Business (2016-2021) & (US$ Million)
Table 70. Allergan plc Recent Development
Table 71. Angelini Group Company Details
Table 72. Angelini Group Business Overview
Table 73. Angelini Group Ocular Hypertension Treatment Product
Table 74. Angelini Group Revenue in Ocular Hypertension Treatment Business (2016-2021) & (US$ Million)
Table 75. Angelini Group Recent Development
Table 76. Chong Kun Dang Pharmaceutical Corp. Company Details
Table 77. Chong Kun Dang Pharmaceutical Corp. Business Overview
Table 78. Chong Kun Dang Pharmaceutical Corp. Ocular Hypertension Treatment Product
Table 79. Chong Kun Dang Pharmaceutical Corp. Revenue in Ocular Hypertension Treatment Business (2016-2021) & (US$ Million)
Table 80. Chong Kun Dang Pharmaceutical Corp. Recent Development
Table 81. SALVAT SA Company Details
Table 82. SALVAT SA Business Overview
Table 83. SALVAT SA Ocular Hypertension Treatment Product
Table 84. SALVAT SA Revenue in Ocular Hypertension Treatment Business (2016-2021) & (US$ Million)
Table 85. SALVAT SA Recent Development
Table 86. Sophia SA de CV Company Details
Table 87. Sophia SA de CV Business Overview
Table 88. Sophia SA de CV Ocular Hypertension Treatment Product
Table 89. Sophia SA de CV Revenue in Ocular Hypertension Treatment Business (2016-2021) & (US$ Million)
Table 90. Sophia SA de CV Recent Development
Table 91. Lee's Pharmaceutical Holdings Ltd. Company Details
Table 92. Lee's Pharmaceutical Holdings Ltd. Business Overview
Table 93. Lee's Pharmaceutical Holdings Ltd. Ocular Hypertension Treatment Product
Table 94. Lee's Pharmaceutical Holdings Ltd. Revenue in Ocular Hypertension Treatment Business (2016-2021) & (US$ Million)
Table 95. Lee's Pharmaceutical Holdings Ltd. Recent Development
Table 96. Neurim Pharmaceuticals Ltd. Company Details
Table 97. Neurim Pharmaceuticals Ltd. Business Overview
Table 98. Neurim Pharmaceuticals Ltd. Revenue in Ocular Hypertension Treatment Business (2016-2021) & (US$ Million)
Table 99. Neurim Pharmaceuticals Ltd. Recent Development
Table 100. NicOx SA Company Details
Table 101. NicOx SA Business Overview
Table 102. NicOx SA Ocular Hypertension Treatment Product
Table 103. NicOx SA Revenue in Ocular Hypertension Treatment Business (2016-2021) & (US$ Million)
Table 104. NicOx SA Recent Development
Table 105. Novartis AG Company Details
Table 106. Novartis AG Business Overview
Table 107. Novartis AG Ocular Hypertension Treatment Product
Table 108. Novartis AG Revenue in Ocular Hypertension Treatment Business (2016-2021) & (US$ Million)
Table 109. Novartis AG Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ocular Hypertension Treatment Market Share by Type: 2020 VS 2027
Figure 2. Intraocular Hypertension Features
Figure 3. Glaucoma Features
Figure 4. Global Ocular Hypertension Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Specialty Clinics Case Studies
Figure 7. Others Case Studies
Figure 8. Ocular Hypertension Treatment Report Years Considered
Figure 9. Global Ocular Hypertension Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Ocular Hypertension Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Ocular Hypertension Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Ocular Hypertension Treatment Market Share by Regions (2022-2027)
Figure 13. Global Ocular Hypertension Treatment Market Share by Players in 2020
Figure 14. Global Top Ocular Hypertension Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ocular Hypertension Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Ocular Hypertension Treatment Revenue in 2020
Figure 16. Global Ocular Hypertension Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Ocular Hypertension Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Ocular Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Ocular Hypertension Treatment Market Share by Type (2016-2027)
Figure 20. North America Ocular Hypertension Treatment Market Share by Application (2016-2027)
Figure 21. North America Ocular Hypertension Treatment Market Share by Country (2016-2027)
Figure 22. United States Ocular Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Ocular Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Ocular Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Ocular Hypertension Treatment Market Share by Type (2016-2027)
Figure 26. Europe Ocular Hypertension Treatment Market Share by Application (2016-2027)
Figure 27. Europe Ocular Hypertension Treatment Market Share by Country (2016-2027)
Figure 28. Germany Ocular Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Ocular Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Ocular Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Ocular Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Ocular Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Ocular Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Ocular Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Ocular Hypertension Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Ocular Hypertension Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Ocular Hypertension Treatment Market Share by Region (2016-2027)
Figure 38. China Ocular Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Ocular Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Ocular Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Ocular Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Ocular Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Ocular Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Ocular Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Ocular Hypertension Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Ocular Hypertension Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Ocular Hypertension Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Ocular Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Ocular Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Ocular Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Ocular Hypertension Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Ocular Hypertension Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Ocular Hypertension Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Ocular Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Ocular Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Ocular Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Aerie Pharmaceuticals, Inc. Revenue Growth Rate in Ocular Hypertension Treatment Business (2016-2021)
Figure 58. Allergan plc Revenue Growth Rate in Ocular Hypertension Treatment Business (2016-2021)
Figure 59. Angelini Group Revenue Growth Rate in Ocular Hypertension Treatment Business (2016-2021)
Figure 60. Chong Kun Dang Pharmaceutical Corp. Revenue Growth Rate in Ocular Hypertension Treatment Business (2016-2021)
Figure 61. SALVAT SA Revenue Growth Rate in Ocular Hypertension Treatment Business (2016-2021)
Figure 62. Sophia SA de CV Revenue Growth Rate in Ocular Hypertension Treatment Business (2016-2021)
Figure 63. Lee's Pharmaceutical Holdings Ltd. Revenue Growth Rate in Ocular Hypertension Treatment Business (2016-2021)
Figure 64. Neurim Pharmaceuticals Ltd. Revenue Growth Rate in Ocular Hypertension Treatment Business (2016-2021)
Figure 65. NicOx SA Revenue Growth Rate in Ocular Hypertension Treatment Business (2016-2021)
Figure 66. Novartis AG Revenue Growth Rate in Ocular Hypertension Treatment Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

以下、関連資料のご紹介

世界の眼炎症治療市場規模・現状・予測（2021年-2027年）

Global Ocular Inflammation Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4225 2021年4月 98Pages
QYResearch社発行の本調査資料では、眼炎症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（免疫抑制剤、モノクローナル抗体、コルチコステロイド、毛様体筋麻痺薬、抗生物質、鎮痛剤、抗ウイルス剤、抗真菌剤）、用途別市場規模（小売薬局、病院...

世界の眼炎症治療市場規模・現状・予測（2021年-2027年）

世界の肺動脈性肺高血圧症治療市場規模・現状・予測（2021年-2027年）

Global Pulmonary Arterial Hypertension Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4864 2021年4月 94Pages
QYResearch社発行の本調査資料では、肺動脈性肺高血圧症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（血管拡張薬、ホスホジエステラーゼ5（PDE 5）阻害薬、エンドセリン受容体拮抗薬（ERA）、可溶性グアニル酸シクラーゼ（SGC）刺...

世界の高血圧・心不全治療市場規模・現状・予測（2021年-2027年）

Global Hypertension and Heart Failure Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3000 2021年4月 93Pages
QYResearch社発行の本調査資料では、高血圧・心不全治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（利尿薬、β遮断薬、エース阻害薬、α遮断薬、その他）、用途別市場規模（男性、女性）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジ...

世界の特発性頭蓋内圧亢進症治療市場規模・現状・予測（2021年-2027年）

Global Idiopathic Intracranial Hypertension Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3017 2021年4月 127Pages
QYResearch社発行の本調査資料では、特発性頭蓋内圧亢進症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アセタゾラミド、メタゾラミド、フロセミド、トピラマート、その他）、用途別市場規模（病院、クリニック、外来手術センター）、主要地域...

世界の肺動脈性肺高血圧症（PAH）市場規模・現状・予測（2021年-2027年）

Global Pulmonary Arterial Hypertension (PAH) Market Size, Status and Forecast 2021-2027
QYR2104Z4863 2021年4月 90Pages
QYResearch社発行の本調査資料では、肺動脈性肺高血圧症（PAH）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（プロスタサイクリン＆プロスタサイクリン類似体、SGC刺激剤、ERA、PDE-5）、用途別市場規模（病院、診療所）、主要地域別...

世界の眼科用ドラッグデリバリー技術市場規模・現状・予測（2021年-2027年）

Global Ocular Drug Delivery Technology Market Size, Status and Forecast 2021-2027
QYR2104Z4223 2021年4月 94Pages
QYResearch社発行の本調査資料では、眼科用ドラッグデリバリー技術のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（光学、眼球挿入物、イオントフォレーシス、眼内インプラント）、用途別市場規模（病院、外来手術センター、クリニック）、主要地域別...

世界の慢性血栓塞栓性肺高血圧症（CTEPH）市場規模・現状・予測（2021年-2027年）

Global Chronic Thromboembolic Pulmonary Hypertension Market Size, Status and Forecast 2021-2027
QYR2104Z1329 2021年4月 99Pages
QYResearch社発行の本調査資料では、慢性血栓塞栓性肺高血圧症（CTEPH）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経胸壁心エコー図（TTE）、換気灌流（V / Q）スキャン、肺血管造影、心臓カテーテル検査、コンピューター断層撮影...

世界の後天性血友病A治療市場規模・現状・予測（2021年-2027年）

Global Acquired hemophilia A Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0029 2021年4月 97Pages
QYResearch社発行の本調査資料では、後天性血友病A治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（200IU、250IU）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、イン...

世界のスウェーデンポルフィリン症治療市場規模・現状・予測（2021年-2027年）

Global Swedish Porphyria Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5520 2021年4月 99Pages
QYResearch社発行の本調査資料では、スウェーデンポルフィリン症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（350mg、313mg）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国...

世界の肺動脈性肺高血圧症治療市場規模・現状・予測（2021年-2027年） Pulmonary arterial hypertension- commonly known as PAH- is characterized by increased pressure in the pulmonary arteries due to structural changes in blood vessel walls, aggregation of platelets and alteration of smooth muscle cell function- eventually elevating pressure in the pulmonary arteries re…
世界の高血圧・心不全治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Hypertension and Heart Failure Treatment Market The global Hypertension and Heart Failure Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analys…
世界の特発性頭蓋内圧亢進症治療市場規模・現状・予測（2021年-2027年） Idiopathic intracranial hypertension is characterized by a buildup of the cerebrospinal fluid causing increase in the blood volume in vessels surrounding the brain and increase in brain swelling. The increase in salt intake causes water retention in the body together with fat adding on to the calori…
世界の眼炎症治療市場規模・現状・予測（2021年-2027年） Eye inflammations or uveitis are becoming a common problem for people across global geographies. New drugs are being discovered to treat ocular inflammations, and companies are investing millions for their approval through regulatory pipelines. Patients are exhibiting a particular preference to the …
世界の眼炎症治療市場規模・現状・予測（2021年-2027年） Eye inflammations or uveitis are becoming a common problem for people across global geographies. New drugs are being discovered to treat ocular inflammations, and companies are investing millions for their approval through regulatory pipelines. Patients are exhibiting a particular preference to the …